ARCHIVES

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

This article is from The Cancer Letter archive.

Vol. 24 No. 21 | May 29, 1998

Download PDF Visit The Full Archive

Related Articles

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

DOD Bill Passes Senate; Prostate Cancer Gets $75 Mil.; Breast Cancer Recieves $175 Mil.

June 25, 1999

In Brief: Little Doubt That DeVita, Frederickson Will Keep Their Jobs; New DCT Projects May Not Be Funded

March 6, 1981

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010

National Health Organizations Warn of Risks in Indoor Tanning

April 29, 2011